Metkefamide
Hepatic[1] | |
Elimination half-life | ~60 minutes[3] |
---|---|
Identifiers | |
| |
JSmol) | |
| |
|
Metkefamide (
Despite its
pain relief that lasts for hours.[3]
Likely on account of its δ-opioid activity,
sensations of heaviness in the extremities and nasal congestion—though these were not considered to be particularly distressing[9]—and it has also been shown to raise the seizure threshold in animals.[13] In any case, clinical development was not further pursued after phase I clinical studies and metkefamide never reached the pharmaceutical market.[14][15][16]
See also
References
- ^ ISBN 978-0-85404-227-2. Retrieved 27 April 2012.
- ISBN 978-3-527-32994-6. Retrieved 27 April 2012.
- ^ ISBN 978-0-8247-7896-5. Retrieved 27 April 2012.
- ISBN 978-0-7514-0499-9. Retrieved 27 April 2012.
- S2CID 3872497.
- ^ PMID 6256856.
- ISBN 978-0-89603-306-1. Retrieved 27 April 2012.
- PMID 2553920.
- ^ S2CID 9618418.
- PMID 6292609.
- ISBN 978-0-8247-1995-1. Retrieved 27 April 2012.
- ISBN 978-0-8247-8346-4. Retrieved 27 April 2012.
- PMID 6319916.
- ISBN 978-0-12-040522-0. Retrieved 27 April 2012.
- ISBN 978-0-7881-8196-2. Retrieved 27 April 2012.
- ISBN 978-0-412-46630-4. Retrieved 26 April 2012.